Searched for
RETATRUTIDE
US stocks: S&P 500, Nasdaq end up as tech, chipmakers reboundU.S. stocks largely rose Monday, with the Nasdaq and chipmakers leading the gains as investors sought bargains after Friday's selloff. Reli...- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- US stocks today: US market gains as semiconductor stocks rebound, Middle East tensions easeMajor Wall Street indexes saw a strong rebound. This recovery was driven by gains in chip stocks. Signs of de-escalation in Middle East ten...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- Eli Lilly’s obesity drug shows up to 30% weight loss in trialEli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This onc...
- Iran war impact: Essential drugs may cost up to 5% more, for nowThe immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...
- India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- Jhunjhunwalas-backed IKS healthcare looks to acquire TruBridge for $600 millionInventurus Knowledge Solutions (IKS), backed by the family of late investor Rakesh Jhunjhunwala, is in advanced talks to acquire Nasdaq-lis...
- India is well positioned to attract future investments, says Eli Lilly's Patrik JonssonEli Lilly's Patrik Jonsson urges India to accelerate regulatory review pathways to boost competitiveness, emphasizing the need for data pro...
- India is well positioned to attract future investments: Patrik Jonsson, President, Lilly InternationalEli Lilly's Patrik Jonsson urges India to accelerate regulatory review pathways to boost competitiveness, emphasizing the need for stronger...
- 'Chinese peptides' are the latest biohacking trend in the tech worldTech professionals are embracing unapproved Chinese peptides for weight loss, fitness, and productivity. These substances, often sourced di...
- Weight-loss treatment: How has obesity medicine market become battleground for pharma giants like Pfizer, AstraZeneca, Eli Lilly?Obesity, weight-loss medicines: Novo has been scrambling to keep pace in the obesity drug race it started, losing ground to rival Eli Lilly...
- Hot Stocks: 3 stocks that may give returns between 13-43%Analysts predict significant upside for select stocks, with potential returns ranging from 13% to 43%. Divi's Laboratories is poised to ben...
- Eli Lilly's goal is to reach everyone who needs obesity care: Global CEO David RicksEli Lilly's CEO David Ricks discusses the launch of diabetes and anti-obesity drugs Mounjaro and Zepbound, focusing on expanding access in ...
- Novo Nordisk inks $2-billion obesity drug deal with United LabsNovo will pay Hong Kong-based United Laboratories $200 million upfront for the drug, which combines three different mechanisms in an effort...
- What can a wonder drug maker and a phone maker have in common? Their fall from graceNovo Nordisk's reign as Europe's most valuable company is facing a challenge from US rival Eli Lilly. Lilly's weight-loss drug, Zepbound, i...
- Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in IndiaDoctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resor...
- What other health conditions might weight-loss drugs treat?New data suggests that semaglutide may also cut the risk of stroke or heart attack, and may delay the progression of kidney disease in diab...
Load More
